• | Core values guided agile response to impact of COVID-19 pandemic; Focused on safety of associates, business continuity and conserving cash while continuing to invest in strategic growth initiatives |
• | Success of Blueprint for Growth Strategy validated with 34.9% gross margin, and record 36.1% adjusted gross margin, despite 12.6% decline in sales |
• | 80/20 Process contributed $5.5 million in operating income in quarter helping to offset volume declines |
• | Net income was $9.2 million, or $0.39 per diluted share; Adjusted net income was $13.8 million, or $0.58 per diluted share |
• | Generated $36.5 million in cash from operations in the quarter |
• | Record annual gross margin was 35.0% despite 7.7% decline in sales |
• | Operating income was $89.8 million, or 11.1% of sales; 80/20 process contributed $20.4 million |
• | Net income was $59.7 million, or $2.50 per diluted share |
• | Achieved 15.7% Adjusted EBTIDA margin and ROIC of 11.5% |
• | Strong working capital management and cash generation delivered record $106.8 million in cash from operations |
• | Ended year with strong balance sheet that provides financial flexibility and significant liquidity |
($ in millions) | Q4 FY 20 | Q4 FY 19 | Change | % Change | ||||||||||
Net sales | $ | 189.5 | $ | 216.7 | $ | (27.2 | ) | (12.6 | )% | |||||
U.S. sales | $ | 104.1 | $ | 120.5 | $ | (16.4 | ) | (13.6 | )% | |||||
% of total | 55 | % | 56 | % | ||||||||||
Non-U.S. sales | $ | 85.4 | $ | 96.2 | $ | (10.8 | ) | (11.2 | )% | |||||
% of total | 45 | % | 44 | % | ||||||||||
($ in millions) | Q4 FY 20 | Q4 FY 19 | Change | % Change | ||||||||||
Gross profit | $ | 66.2 | $ | 76.0 | $ | (9.8 | ) | (12.9 | )% | |||||
Gross margin | 34.9 | % | 35.1 | % | (20) bps | |||||||||
Income from operations | $ | 16.7 | $ | 24.5 | $ | (7.8 | ) | (31.9 | )% | |||||
Operating margin | 8.8 | % | 11.3 | % | (250) bps | |||||||||
Net income | $ | 9.2 | $ | 19.7 | $ | (10.5 | ) | (53.2 | )% | |||||
Diluted EPS | $ | 0.39 | $ | 0.83 | $ | (0.44 | ) | (53.0 | )% | |||||
Adjusted EBITDA * | $ | 27.3 | $ | 32.8 | $ | (5.5 | ) | (16.7 | )% | |||||
Adjusted EBITDA margin | 14.4 | % | 15.1 | % | (70) bps | |||||||||
Gregory P. Rustowicz | Investor Relations: |
Vice President - Finance and Chief Financial Officer | Deborah K. Pawlowski |
Columbus McKinnon Corporation | Kei Advisors LLC |
716-689-5442 | 716-843-3908 |
greg.rustowicz@cmworks.com | dpawlowski@keiadvisors.com |
Three Months Ended | |||||||||||
March 31, 2020 | March 31, 2019 | Change | |||||||||
Net sales | $ | 189,486 | $ | 216,733 | (12.6 | )% | |||||
Cost of products sold | 123,277 | 140,688 | (12.4 | )% | |||||||
Gross profit | 66,209 | 76,045 | (12.9 | )% | |||||||
Gross profit margin | 34.9 | % | 35.1 | % | |||||||
Selling expenses | 22,253 | 23,985 | (7.2 | )% | |||||||
% of net sales | 11.7 | % | 11.1 | % | |||||||
General and administrative expenses | 21,167 | 21,674 | (2.3 | )% | |||||||
% of net sales | 11.2 | % | 10.0 | % | |||||||
Research and development expenses | 2,891 | 3,354 | (13.8 | )% | |||||||
% of net sales | 1.5 | % | 1.5 | % | |||||||
Net loss (gain) on sales of businesses | — | (978 | ) | NM | |||||||
Amortization of intangibles | 3,234 | 3,542 | (8.7 | )% | |||||||
Income from operations | 16,664 | 24,468 | (31.9 | )% | |||||||
Operating margin | 8.8 | % | 11.3 | % | |||||||
Interest and debt expense | 3,200 | 3,959 | (19.2 | )% | |||||||
Investment (income) loss | 48 | (430 | ) | NM | |||||||
Foreign currency exchange (gain) loss | (996 | ) | 637 | NM | |||||||
Other (income) expense, net | 221 | (299 | ) | NM | |||||||
Income before income tax expense | 14,191 | 20,601 | (31.1 | )% | |||||||
Income tax expense | 4,947 | 860 | 475.2 | % | |||||||
Net income | $ | 9,244 | $ | 19,741 | (53.2 | )% | |||||
Average basic shares outstanding | 23,735 | 23,368 | 1.6 | % | |||||||
Basic income (loss) per share | $ | 0.39 | $ | 0.84 | (53.6 | )% | |||||
Average diluted shares outstanding | 23,938 | 23,714 | 0.9 | % | |||||||
Diluted income (loss) per share | $ | 0.39 | $ | 0.83 | (53.0 | )% | |||||
Dividends declared per common share | $ | 0.12 | $ | 0.11 | |||||||
Year Ended | |||||||||||
March 31, 2020 | March 31, 2019 | Change | |||||||||
Net sales | $ | 809,162 | $ | 876,282 | (7.7 | )% | |||||
Cost of products sold | 525,976 | 571,285 | (7.9 | )% | |||||||
Gross profit | 283,186 | 304,997 | (7.2 | )% | |||||||
Gross profit margin | 35.0 | % | 34.8 | % | |||||||
Selling expenses | 91,054 | 97,925 | (7.0 | )% | |||||||
% of net sales | 11.3 | % | 11.2 | % | |||||||
General and administrative expenses | 77,880 | 83,567 | (6.8 | )% | |||||||
% of net sales | 9.6 | % | 9.5 | % | |||||||
Research and development expenses | 11,310 | 13,491 | (16.2 | )% | |||||||
% of net sales | 1.4 | % | 1.5 | % | |||||||
Net loss on sales of businesses, including impairment | 176 | 25,672 | (99.3 | )% | |||||||
Amortization of intangibles | 12,942 | 14,900 | (13.1 | )% | |||||||
Income from operations | 89,824 | 69,442 | 29.4 | % | |||||||
Operating margin | 11.1 | % | 7.9 | % | |||||||
Interest and debt expense | 14,234 | 17,144 | (17.0 | )% | |||||||
Investment (income) loss | (891 | ) | (727 | ) | 22.6 | % | |||||
Foreign currency exchange (gain) loss | (1,514 | ) | 843 | NM | |||||||
Other (income) expense, net | 839 | (716 | ) | NM | |||||||
Income before income tax expense | 77,156 | 52,898 | 45.9 | % | |||||||
Income tax expense | 17,484 | 10,321 | 69.4 | % | |||||||
Net income | $ | 59,672 | $ | 42,577 | 40.2 | % | |||||
Average basic shares outstanding | 23,619 | 23,276 | 1.5 | % | |||||||
Basic income per share | $ | 2.53 | $ | 1.83 | 38.3 | % | |||||
Average diluted shares outstanding | 23,855 | 23,660 | 0.8 | % | |||||||
Diluted income per share | $ | 2.50 | $ | 1.80 | 38.9 | % | |||||
Dividends declared per common share | $ | 0.24 | $ | 0.21 | |||||||
March 31, 2020 | March 31, 2019 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 114,450 | $ | 71,093 | ||||
Trade accounts receivable | 123,743 | 129,157 | ||||||
Inventories | 127,373 | 146,263 | ||||||
Prepaid expenses and other | 17,180 | 16,075 | ||||||
Total current assets | 382,746 | 362,588 | ||||||
Property, plant, and equipment, net | 79,473 | 87,303 | ||||||
Goodwill | 319,679 | 322,816 | ||||||
Other intangibles, net | 217,962 | 232,940 | ||||||
Marketable securities | 7,322 | 7,028 | ||||||
Deferred taxes on income | 26,281 | 27,707 | ||||||
Other assets | 59,809 | 21,189 | ||||||
Total assets | $ | 1,093,272 | $ | 1,061,571 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Trade accounts payable | $ | 57,289 | $ | 46,974 | ||||
Accrued liabilities | 93,585 | 99,304 | ||||||
Current portion of long-term debt | 4,450 | 65,000 | ||||||
Total current liabilities | 155,324 | 211,278 | ||||||
Term loan and revolving credit facility | 246,856 | 235,320 | ||||||
Other non-current liabilities | 227,507 | 183,814 | ||||||
Total liabilities | 629,687 | 630,412 | ||||||
Shareholders’ equity: | ||||||||
Common stock | 238 | 234 | ||||||
Additional paid-in capital | 287,256 | 277,518 | ||||||
Retained earnings | 290,441 | 236,459 | ||||||
Accumulated other comprehensive loss | (114,350 | ) | (83,052 | ) | ||||
Total shareholders’ equity | 463,585 | 431,159 | ||||||
Total liabilities and shareholders’ equity | $ | 1,093,272 | $ | 1,061,571 | ||||
Year Ended | ||||||||
March 31, 2020 | March 31, 2019 | |||||||
Operating activities: | ||||||||
Net income | $ | 59,672 | $ | 42,577 | ||||
Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||||||||
Depreciation and amortization | 29,126 | 32,675 | ||||||
Deferred income taxes and related valuation allowance | 7,364 | (958 | ) | |||||
Net loss (gain) on sale of real estate, investments, and other | (563 | ) | 194 | |||||
Stock based compensation | 4,507 | 6,198 | ||||||
Amortization of deferred financing costs | 2,655 | 2,655 | ||||||
Net loss on sales of businesses, including impairment | 176 | 25,672 | ||||||
Non-cash lease expense | 7,923 | — | ||||||
Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures: | ||||||||
Trade accounts receivable | 2,899 | (11,328 | ) | |||||
Inventories | 15,752 | (15,411 | ) | |||||
Prepaid expenses and other | (3,857 | ) | (128 | ) | ||||
Other assets | 724 | 231 | ||||||
Trade accounts payable | 8,110 | 3,881 | ||||||
Accrued liabilities | (14,304 | ) | 6,397 | |||||
Non-current liabilities | (13,389 | ) | (13,156 | ) | ||||
Net cash provided by (used for) operating activities | 106,795 | 79,499 | ||||||
Investing activities: | ||||||||
Proceeds from sales of marketable securities | 5,380 | 3,266 | ||||||
Purchases of marketable securities | (5,747 | ) | (2,604 | ) | ||||
Capital expenditures | (9,432 | ) | (12,288 | ) | ||||
Proceeds from sale of equipment and real estate | 51 | 176 | ||||||
Net (payments) proceeds from sales of businesses | (214 | ) | 14,230 | |||||
Payment of restricted cash to former owner | — | (294 | ) | |||||
Net cash provided by (used for) investing activities | (9,962 | ) | 2,486 | |||||
Financing activities: | ||||||||
Proceeds from issuance of common stock | 6,000 | 4,152 | ||||||
Repayment of debt | (51,113 | ) | (65,088 | ) | ||||
Payment of dividends | (5,670 | ) | (4,652 | ) | ||||
Other | (768 | ) | (2,190 | ) | ||||
Net cash provided by (used for) financing activities | (51,551 | ) | (67,778 | ) | ||||
Effect of exchange rate changes on cash | (1,925 | ) | (6,429 | ) | ||||
Net change in cash and cash equivalents | 43,357 | 7,778 | ||||||
Cash, cash equivalents, and restricted cash at beginning of year | 71,343 | 63,565 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 114,700 | $ | 71,343 | ||||
Quarter | Year To Date | |||||||||||||
($ in millions) | $ Change | % Change | $ Change | % Change | ||||||||||
Fiscal 2019 Sales | $ | 216.7 | $ | 876.3 | ||||||||||
Divestitures | (4.8 | ) | (34.2 | ) | ||||||||||
Fiscal 2019 Sales adjusted for divestitures | $ | 211.9 | $ | 842.1 | ||||||||||
Volume | (22.9 | ) | (10.8 | )% | (33.0 | ) | (3.9 | )% | ||||||
Pricing | 2.8 | 1.3 | % | 13.2 | 1.6 | % | ||||||||
Foreign currency translation | (2.3 | ) | (1.1 | )% | (13.1 | ) | (1.6 | )% | ||||||
Total change adjusted for divestitures | $ | (22.4 | ) | (10.6 | )% | $ | (32.9 | ) | (3.9 | )% | ||||
Fiscal 2020 Sales | $ | 189.5 | $ | 809.2 | ||||||||||
($ in millions) | Quarter | Year To Date | |||||
Fiscal 2019 Gross Profit | $ | 76.0 | $ | 305.0 | |||
Divestitures | (0.9 | ) | (7.1 | ) | |||
Fiscal 2019 Gross Profit adjusted for divestitures | 75.1 | 297.9 | |||||
Pricing, net of material cost inflation | 2.5 | 10.3 | |||||
Insurance settlement | — | 0.4 | |||||
Product liability | (0.3 | ) | (0.6 | ) | |||
Business realignment costs | (0.8 | ) | (0.7 | ) | |||
Tariffs | 0.4 | (0.8 | ) | ||||
Factory closures | — | (1.3 | ) | ||||
Productivity, net of other cost changes | (1.6 | ) | (3.4 | ) | |||
Foreign currency translation | (0.8 | ) | (4.5 | ) | |||
Sales volume and mix | (8.3 | ) | (14.1 | ) | |||
Total change adjusted for divestitures | $ | (8.9 | ) | $ | (14.7 | ) | |
Fiscal 2020 Gross Profit | $ | 66.2 | $ | 283.2 | |||
March 31, 2020 | December 31, 2019 | March 31, 2019 | |||||||||||||
($ in millions) | |||||||||||||||
Backlog | $ | 131.0 | $ | 125.3 | $ | 161.5 | |||||||||
Long-term backlog | |||||||||||||||
Expected to ship beyond 3 months | $ | 49.1 | $ | 51.3 | $ | 61.7 | |||||||||
Long-term backlog as % of total backlog | 37.5 | % | 40.9 | % | 38.2 | % | |||||||||
Trade accounts receivable | |||||||||||||||
Days sales outstanding (1) | 59.4 | days | 57.2 | days | 55.5 | days | |||||||||
Inventory turns per year (1) | |||||||||||||||
(based on cost of products sold) | 3.9 | turns | 3.9 | turns | 3.7 | turns | |||||||||
Days' inventory (1) | 94.3 | days | 94.0 | days | 97.6 | days | |||||||||
Trade accounts payable | |||||||||||||||
Days payables outstanding (1) | 42.3 | days | 32.1 | days | 31.3 | days | |||||||||
Working capital as a % of sales (1), (2) | 14.5 | % | 16.5 | % | 17.2 | % | |||||||||
Debt to total capitalization percentage | 35.2 | % | 34.2 | % | 41.1 | % | |||||||||
Debt, net of cash, to net total capitalization | 22.8 | % | 25.7 | % | 34.7 | % | |||||||||
U.S. Shipping Days by Quarter | ||||||||||
Q1 | Q2 | Q3 | Q4 | Total | ||||||
FY 21 | 63 | 64 | 61 | 63 | 251 | |||||
FY 20 | 63 | 63 | 61 | 64 | 251 | |||||
FY 19 | 64 | 63 | 60 | 63 | 250 | |||||
Three Months Ended March 31, | Year Ended March 31, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Gross profit | $ | 66,209 | $ | 76,045 | $ | 283,186 | $ | 304,997 | |||||||
Add back (deduct): | |||||||||||||||
Factory closures | 1,349 | 1,273 | 2,800 | 1,473 | |||||||||||
Business realignment costs | 774 | — | 1,037 | 286 | |||||||||||
Insurance settlement | (15 | ) | — | (382 | ) | — | |||||||||
Non-GAAP adjusted gross profit | $ | 68,317 | $ | 77,318 | $ | 286,641 | $ | 306,756 | |||||||
Sales | $ | 189,486 | $ | 216,733 | $ | 809,162 | $ | 876,282 | |||||||
Adjusted gross margin | 36.1 | % | 35.7 | % | 35.4 | % | 35.0 | % | |||||||
Three Months Ended March 31, | Year Ended March 31, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Income from operations | $ | 16,664 | $ | 24,468 | $ | 89,824 | $ | 69,442 | |||||||
Add back (deduct): | |||||||||||||||
Factory closures | 1,621 | 1,273 | 4,709 | 1,473 | |||||||||||
Business realignment costs | 1,755 | — | 2,831 | 1,906 | |||||||||||
Insurance recovery legal costs | 160 | 132 | 585 | 1,282 | |||||||||||
Net loss (gain) on sales of businesses, including impairment | — | (978 | ) | 176 | 25,672 | ||||||||||
Insurance settlement | (15 | ) | — | (382 | ) | — | |||||||||
Non-GAAP adjusted income from operations | $ | 20,185 | $ | 24,895 | $ | 97,743 | $ | 99,775 | |||||||
Sales | $ | 189,486 | $ | 216,733 | $ | 809,162 | $ | 876,282 | |||||||
Adjusted operating margin | 10.7 | % | 11.5 | % | 12.1 | % | 11.4 | % | |||||||
Three Months Ended March 31, | Year Ended March 31, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Net income | $ | 9,244 | $ | 19,741 | $ | 59,672 | $ | 42,577 | |||||||
Add back (deduct): | |||||||||||||||
Factory closures | 1,621 | 1,273 | 4,709 | 1,473 | |||||||||||
Business realignment costs | 1,755 | — | 2,831 | 1,906 | |||||||||||
Insurance recovery legal costs | 160 | 132 | 585 | 1,282 | |||||||||||
Net loss (gain) on sales of businesses, including impairment | — | (978 | ) | 176 | 25,672 | ||||||||||
Insurance settlement | (15 | ) | — | (382 | ) | — | |||||||||
Normalize tax rate to 22% (1) | 1,050 | (3,766 | ) | (1,232 | ) | (7,990 | ) | ||||||||
Non-GAAP adjusted net income | $ | 13,815 | $ | 16,402 | $ | 66,359 | $ | 64,920 | |||||||
Average diluted shares outstanding | 23,938 | 23,714 | 23,855 | 23,660 | |||||||||||
Diluted income per share - GAAP | $ | 0.39 | $ | 0.83 | $ | 2.50 | $ | 1.80 | |||||||
Diluted income per share - Non-GAAP | $ | 0.58 | $ | 0.69 | $ | 2.78 | $ | 2.74 | |||||||
Three Months Ended March 31, | Year Ended March 31, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Net income | $ | 9,244 | $ | 19,741 | $ | 59,672 | $ | 42,577 | |||||||
Add back (deduct): | |||||||||||||||
Income tax expense | 4,947 | 860 | 17,484 | 10,321 | |||||||||||
Interest and debt expense | 3,200 | 3,959 | 14,234 | 17,144 | |||||||||||
Investment (income) loss | 48 | (430 | ) | (891 | ) | (727 | ) | ||||||||
Foreign currency exchange (gain) loss | (996 | ) | 637 | (1,514 | ) | 843 | |||||||||
Other (income) expense, net | 221 | (299 | ) | 839 | (716 | ) | |||||||||
Depreciation and amortization expense | 7,135 | 7,912 | 29,126 | 32,675 | |||||||||||
Factory closures | 1,621 | 1,273 | 4,709 | 1,473 | |||||||||||
Business realignment costs | 1,755 | — | 2,831 | 1,906 | |||||||||||
Insurance recovery legal costs | 160 | 132 | 585 | 1,282 | |||||||||||
Net loss (gain) on sales of businesses, including impairment | — | (978 | ) | 176 | 25,672 | ||||||||||
Insurance settlement | (15 | ) | — | (382 | ) | — | |||||||||
Non-GAAP adjusted EBITDA | $ | 27,320 | $ | 32,807 | $ | 126,869 | $ | 132,450 | |||||||
Sales | $ | 189,486 | $ | 216,733 | $ | 809,162 | $ | 876,282 | |||||||
Adjusted EBITDA margin | 14.4 | % | 15.1 | % | 15.7 | % | 15.1 | % | |||||||